We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTPH
351
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$3.18M 0.06%
25,250
+5,600
+28% +$717K
NSC icon
352
Norfolk Southern
NSC
$78.8B
$3.17M 0.05%
21,883
+1,716
+9% +$230K
RJF icon
353
Raymond James Financial
RJF
$32.5B
$3.17M 0.05%
53,183
-46,959
-47% -$2.71M
ANDV
354
DELISTED
Andeavor
ANDV
$3.15M 0.05%
27,594
+5,400
+24% +$581K
AVXS
355
DELISTED
AveXis, Inc. Common Stock
AVXS
$3.15M 0.05%
28,500
SIRI icon
356
SiriusXM
SIRI
$10B
$3.15M 0.05%
58,832
+47,810
+434% +$2.64M
JD icon
357
JD.com
JD
$40.8B
$3.13M 0.05%
75,610
-68,000
-47% -$2.68M
CTSH icon
358
Cognizant
CTSH
$21.5B
$3.12M 0.05%
43,977
+2,927
+7% +$214K
XLRN
359
DELISTED
Acceleron Pharma
XLRN
$3.1M 0.05%
73,000
-45,000
-38% -$1.69M
PFG icon
360
Principal Financial Group
PFG
$23.6B
$3.1M 0.05%
43,864
+2,371
+6% +$163K
TMUS icon
361
T-Mobile US
TMUS
$193B
$3.06M 0.05%
48,177
-14,560
-23% -$888K
FISV
362
Fiserv Inc
FISV
$27.2B
$3.06M 0.05%
46,646
+496
+1% +$32K
GHDX
363
DELISTED
Genomic Health, Inc.
GHDX
$3.04M 0.05%
89,000
-10,000
-10% -$319K
GWPH
364
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.04M 0.05%
23,000
-6,000
-21% -$705K
ICE icon
365
Intercontinental Exchange
ICE
$82.4B
$2.99M 0.05%
42,325
SPPI
366
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2.98M 0.05%
+157,000
New +$2.84M
NUE icon
367
Nucor
NUE
$56.4B
$2.95M 0.05%
46,369
-2,376
-5% -$139K
LUMN icon
368
Lumen
LUMN
$6.53B
$2.93M 0.05%
175,520
+42,221
+32% +$716K
CAG icon
369
Conagra Brands
CAG
$7.07B
$2.92M 0.05%
77,519
+9,325
+14% +$331K
SBAC icon
370
SBA Communications
SBAC
$18.4B
$2.91M 0.05%
17,788
+6,149
+53% +$977K
STZ icon
371
Constellation Brands
STZ
$22.2B
$2.88M 0.05%
12,603
+1,334
+12% +$288K
RCI icon
372
Rogers Communications
RCI
$17.7B
$2.87M 0.05%
56,203
-16,286
-22% -$849K
EXC icon
373
Exelon
EXC
$48.6B
$2.87M 0.05%
102,005
+17,010
+20% +$489K
AEE icon
374
Ameren
AEE
$31.5B
$2.87M 0.05%
48,582
+37,711
+347% +$2.32M
FTV icon
375
Fortive
FTV
$19B
$2.84M 0.05%
62,227
+8,244
+15% +$377K

Similar funds

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.